MEI Pharma Inc reports results for the quarter ended in December - Earnings Summary

Lite Strategy

14/02/2024 12:00

* MEI Pharma Inc  MEIP.OQ  reported a quarterly adjusted
loss of
$1.66​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of
$1.60.  The mean expectation of three analysts for the quarter
was for a loss of $1.32 per share. Wall Street expected
results to range from $-1.33 to $-1.32 per share.
    * Reported revenue was zero​; analysts expected $100.00
thousand. 
    * MEI Pharma Inc's reported EPS for the quarter was a loss
of
$1.66​.
    * The company reported a quarterly loss of $11.06 million.
    * MEI Pharma Inc shares had fallen by 20.2% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for MEI Pharma
Inc is
$20.00 

This summary was machine generated from LSEG data February 14 at
12:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -1.32          -1.66          Missed
 Sep. 30 2023      -2.12          8.46           Beat
 Jun. 30 2023      -2.41          -1.51          Beat
 Mar. 31 2023      -2.87          -2.32          Beat